Fats and Glyceridic oils, salmon
CAS 68991-43-5
Fats and Glyceridic oils, salmon (CAS 68991-43-5) is a pharmaceutical compound with 0 bioactivity targets and 356 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Fats and Glyceridic oils, salmon is linked to DTXSID401009756 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Fats and Glyceridic oils, salmon used for in pharmaceutical contexts?
Fats and Glyceridic oils, salmon (CAS 68991-43-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Fats and Glyceridic oils, salmon?
Fats and Glyceridic oils, salmon has 356 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Autoimmune disorder, Blister. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Fats and Glyceridic oils, salmon also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Salmo Oil with EU status "permitted".
What clinical phase is Fats and Glyceridic oils, salmon in?
No phase 1-4 clinical development badge is rendered for Fats and Glyceridic oils, salmon because the matched compound identifier rows do not contain a max-phase value.